Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (161-170 of 607) with videos related to

Pageof 61
Sort By:
Journal of Cell Communication and Signaling|July 20, 2011
Elevated CCN2 expression in scleroderma: a putative role for the TGFβ accessory receptors TGFβRIII and endoglinAlan M Holmes, Markella Ponticos, Xu Shi-Wen, et al.
ACR Open Rheumatology|January 23, 2025
Impact of Scleroderma-Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial of Tocilizumab in SclerodermaBasmah Al Dulaijan, Suiyuan Huang, Celia J F Lin, et al.
British Journal of Rheumatology|March 6, 1998
Anti-RNA polymerases and other autoantibody specificities in systemic sclerosisC C Bunn, C P Denton, X Shi-Wen, et al.
The Journal of Rheumatology|February 15, 2023
A Phenome-Wide Association Study of Drugs and Comorbidities Associated With Gastrointestinal Dysfunction in Systemic SclerosisRory H Maclean, Fiza Ahmed, Voon H Ong, et al.
Journal of Diabetes and Its Complications|August 5, 2000
Quality of life associated with diabetes mellitus in an adult populationG C Brown, M M Brown, S Sharma, et al.
The Journal of Rheumatology|April 1, 1996
Scleroderma fibroblast phenotype is modulated by endothelial cell co-cultureC P Denton, S Xu, K I Welsh, et al.
Annals of the Rheumatic Diseases|July 3, 2007
Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?M T Carulli, C Handler, J G Coghlan, et al.
Lancet (London, England)|June 18, 2013
Autologous HSCT for systemic sclerosisJacob M van Laar, Svetlana I Nihtyanova, Kamran Naraghi, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
COVID-19 and systemic sclerosis: Rising to the challenge of a pandemicChristopher P Denton, Corrado Campochiaro, Cosimo Bruni, et al.
RMD Open|October 17, 2025
Nailfold capillaroscopy in patients with systemic sclerosis-associated interstitial lung disease: a substudy of the SENSCIS trialVanessa Smith, Christopher P Denton, Ariane L Herrick, et al.
Pageof 61

Showing results (161-170 of 607) with videos related to

Sort By:
Pageof 61
Journal of Cell Communication and Signaling|July 20, 2011
Elevated CCN2 expression in scleroderma: a putative role for the TGFβ accessory receptors TGFβRIII and endoglinAlan M Holmes, Markella Ponticos, Xu Shi-Wen, et al.
ACR Open Rheumatology|January 23, 2025
Impact of Scleroderma-Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial of Tocilizumab in SclerodermaBasmah Al Dulaijan, Suiyuan Huang, Celia J F Lin, et al.
British Journal of Rheumatology|March 6, 1998
Anti-RNA polymerases and other autoantibody specificities in systemic sclerosisC C Bunn, C P Denton, X Shi-Wen, et al.
The Journal of Rheumatology|February 15, 2023
A Phenome-Wide Association Study of Drugs and Comorbidities Associated With Gastrointestinal Dysfunction in Systemic SclerosisRory H Maclean, Fiza Ahmed, Voon H Ong, et al.
Journal of Diabetes and Its Complications|August 5, 2000
Quality of life associated with diabetes mellitus in an adult populationG C Brown, M M Brown, S Sharma, et al.
The Journal of Rheumatology|April 1, 1996
Scleroderma fibroblast phenotype is modulated by endothelial cell co-cultureC P Denton, S Xu, K I Welsh, et al.
Annals of the Rheumatic Diseases|July 3, 2007
Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?M T Carulli, C Handler, J G Coghlan, et al.
Lancet (London, England)|June 18, 2013
Autologous HSCT for systemic sclerosisJacob M van Laar, Svetlana I Nihtyanova, Kamran Naraghi, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
COVID-19 and systemic sclerosis: Rising to the challenge of a pandemicChristopher P Denton, Corrado Campochiaro, Cosimo Bruni, et al.
RMD Open|October 17, 2025
Nailfold capillaroscopy in patients with systemic sclerosis-associated interstitial lung disease: a substudy of the SENSCIS trialVanessa Smith, Christopher P Denton, Ariane L Herrick, et al.
Pageof 61